Experimental pill targets specific cancer mutations in patients out of options
Disease control
Completed
This study tested an oral medication called ENV-101 in adults with advanced solid tumors that have a specific genetic change (PTCH1 mutation) and have stopped responding to standard treatments. The goal was to see if the drug could shrink tumors and was safe to take. Researchers …
Phase: PHASE2 • Sponsor: Endeavor Biomedicines, Inc. • Aim: Disease control
Last updated Apr 02, 2026 05:57 UTC